Psychotic relapse in a patient with schizophrenia associated with modafinil therapy

Primary Psychiatry

Volumn 16, Issue 11, 2009, Pages 26-27

  Aggarwal, Ashish ^a   Garg, Amit ^b   Jiloha, Ram C ^b  

^a INDIRA GANDHI MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; LORAZEPAM; MODAFINIL; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL HEALTH; MOSLEM; NARCOLEPSY; PERSECUTORY DELUSION; PSYCHOSIS; RELAPSE; SCHIZOPHRENIA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

EID: 75449104636     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Erman MK, Rosenberg R, for the U S Modafinil Shift Work Sleep Disorder Study Group. "Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life". Prim Care Companion J Clin Psychiatry. 2007;9(3):188-194.
2. Minzenberg MJ, Carter CS: Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008;33(7):1477-1502.
3. Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. J Clin Psychiatry. 2009;70(1):104-112.
4. International Statistical Classification of Diseases and Health Related Problems. 10th rev. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
6. Wu P, Jones S, Ryan CJ, Michail D, Robinson TD. Modafinil-induced psychosis. Intern Med J. 2008;38(8):677-678.
7. Mariani JJ, Hart CL. Psychosis associated with modafinil and shift work. Am J Psychiatry. 2005;162(10):1983.
8. Narendran R, Young CM, Valenti AM, Nickolova MK, Pristach CA. Is psychosis exacerbated by modafinil? Arch Gen Psychiatry. 2002;59(3):292-293.
9. Tanganelli S, Fuxe K, Ferraro L, Janson AM, Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea pig: possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1992;345(4):461-465.
10. Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, Miller DK. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants. Eur J Pharmacol. 2007;568(1-3):112-123.